SCHEDULE 13G/A: Deep Track Capital Amends SEC Filing, Reports 4.41% Stake in Guardant Health
Beneficial Ownership Report
Deep Track Capital, LP and its affiliates have filed an amended Schedule 13G, disclosing a 4.41% beneficial ownership stake in Guardant Health, Inc. as of March 31, 2025.
Summary
- Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively reported beneficial ownership of 5,443,721 shares of Guardant Health, Inc. Common Stock.
- This ownership represents 4.41% of Guardant Health's outstanding Common Stock.
- The calculation of the percentage of class is based on 123,421,441 Common Stock outstanding as of February 14, 2025, as reported in Guardant Health's Form 10-K filed on February 20, 2025.
- The filing is an Amendment No. 1 to Schedule 13G, indicating a change from a previous filing.
- The reporting persons have shared voting power and shared dispositive power over all 5,443,721 shares.
- The securities were not acquired and are not held for the purpose of changing or influencing the control of Guardant Health, Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding Guardant Health, Inc.'s future performance or outlook.
Industry Context
This filing is a routine disclosure of institutional ownership in the biotechnology and healthcare sector, indicating a passive investment stake by Deep Track Capital in Guardant Health, a company focused on precision oncology.
Stakeholder Impact
- Shareholders: Provides transparency regarding the ownership structure and significant institutional holdings, indicating a passive investment by Deep Track Capital.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date used for calculating total Common Stock outstanding (123,421,441 shares). |
| 02/20/2025 | Date Guardant Health's Form 10-K, which provided the shares outstanding figure, was filed with the SEC. |
| 03/31/2025 | Date of event which required the filing of this statement. |
| 05/15/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
Guardant Health, Deep Track Capital, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional ownership, biotechnology, healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.